APR Applied Pharma Research s.a. and Labtec GmbH announce positive results of the Ondansetron RapidFilm™ pilot bioequivalence study. Submission of registration dossier anticipated for Q4/2007
APR Applied Pharma Research s.a. and Labtec GmbH announce positive results of the Ondansetron RapidFilm™ pilot bioequivalence study. Submission of registration dossier anticipated for Q4/2007
2015-01-15T18:17:18+00:00Applied Pharma Research (APR)
Holding website 